1
|
Solomon SD, Zelenkofske S, McMurray JJ,
Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A,
Kober L, et al: Sudden death in patients with myocardial infarction
and left ventricular dysfunction, heart failure, or both. N Engl J
Med. 352:2581–2588. 2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Miyauchi Y, Zhou S, Okuyama Y, Miyauchi M,
Hayashi H, Hamabe A, Fishbein MC, Mandel WJ, Chen LS, Chen PS and
Karagueuzian HS: Altered atrial electrical restitution and
heterogeneous sympathetic hyperinnervation in hearts with chronic
left ventricular myocardial infarction: Implications for atrial
fibrillation. Circulation. 108:360–366. 2003. View Article : Google Scholar : PubMed/NCBI
|
3
|
Cao JM, Fishbein MC, Han JB, Lai WW, Lai
AC, Wu TJ, Czer L, Wolf PL, Denton TA, Shintaku IP, et al:
Relationship between regional cardiac hyperinnervation and
ventricular arrhythmia. Circulation. 101:1960–1969. 2000.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Cao JM, Chen LS, KenKnight BH, Ohara T,
Lee MH, Tsai J, Lai WW, Karagueuzian HS, Wolf PL, Fishbein MC and
Chen PS: Nerve sprouting and sudden cardiac death. Circ Res.
86:816–821. 2000. View Article : Google Scholar : PubMed/NCBI
|
5
|
Hasan W, Jama A, Donohue T, Wernli G,
Onyszchuk G, Al-Hafez B, Bilgen M and Smith PG: Sympathetic
hyperinnervation and inflammatory cell NGF synthesis following
myocardial infarction in rats. Brain Res. 1124:142–154. 2006.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Yu T, Zhu W, Gu B, Li S, Wang F, Liu M,
Wei M and Li J: Simvastatin attenuates sympathetic hyperinnervation
to prevent atrial fibrillation during the postmyocardial infarction
remodeling process. J Appl Physiol (1985). 113:1937–1944. 2012.
View Article : Google Scholar : PubMed/NCBI
|
7
|
El-Helou V, Proulx C, Gosselin H, Clement
R, Mimee A, Villeneuve L and Calderone A: Dexamethasone treatment
of post-MI rats attenuates sympathetic innervation of the infarct
region. J Appl Physiol (1985). 104:150–156. 2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wernli G, Hasan W, Bhattacherjee A, van
Rooijen N and Smith PG: Macrophage depletion suppresses sympathetic
hyperinnervation following myocardial infarction. Basic Res
Cardiol. 104:681–693. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Hedger MP and de Kretser DM: The activins
and their binding protein, follistatin-diagnostic and therapeutic
targets in inflammatory disease and fibrosis. Cytokine Growth
Factor Rev. 24:285–295. 2013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Yndestad A, Ueland T, Øie E, Florholmen G,
Halvorsen B, Attramadal H, Simonsen S, Frøland SS, Gullestad L,
Christensen G, et al: Elevated levels of activin A in heart
failure: Potential role in myocardial remodeling. Circulation.
109:1379–1385. 2004. View Article : Google Scholar : PubMed/NCBI
|
11
|
González-Domínguez É, Domínguez-Soto Á,
Nieto C, Flores-Sevilla JL, Pacheco-Blanco M, Campos-Peña V,
Meraz-Ríos MA, Vega MA, Corbí ÁL and Sánchez-Torres C: Atypical
activin A and IL-10 production impairs human CD16+ monocyte
differentiation into anti-inflammatory macrophages. J Immunol.
196:1327–1337. 2016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Sugatani T, Alvarez UM and Hruska KA:
Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for
osteoclast differentiation, but not AKT survival pathway in
osteoclast precursors. J Cell Biochem. 90:59–67. 2003. View Article : Google Scholar : PubMed/NCBI
|
13
|
Scicchitano MS, McFarland DC, Tierney LA,
Boyce RW, Frazier KS, Schwartz LW and Thomas HC: Role of p38 in
regulation of hematopoiesis: Effect of p38 inhibition on cytokine
production and transcription factor activity in human bone marrow
stromal cells. Blood Cells Mol Dis. 40:370–380. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Onai Y, Suzuki J, Maejima Y, Haraguchi G,
Muto S, Itai A and Isobe M: Inhibition of NF-{kappa}B improves left
ventricular remodeling and cardiac dysfunction after myocardial
infarction. Am J Physiol Heart Circ Physiol. 292:H530–H538. 2007.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Levi-Montalcini R: The nerve growth
factor: Its role in growth, differentiation and function of the
sympathetic adrenergic neuron. Prog Brain Res. 45:235–258. 1976.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Glebova NO and Ginty DD: Heterogeneous
requirement of NGF for sympathetic target innervation in vivo. J
Neurosci. 24:743–751. 2004. View Article : Google Scholar : PubMed/NCBI
|
17
|
Hassankhani A, Steinhelper ME, Soonpaa MH,
Katz EB, Taylor DA, Andrade-Rozental A, Factor SM, Steinberg JJ,
Field LJ and Federoff HJ: Overexpression of NGF within the heart of
transgenic mice causes hyperinnervation, cardiac enlargement, and
hyperplasia of ectopic cells. Dev Biol. 169:309–321. 1995.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Soler Palacios B, Estrada-Capetillo L,
Izquierdo E, Criado G, Nieto C, Municio C, González-Alvaro I,
Sánchez-Mateos P, Pablos JL, Corbí AL and Puig-Kröger A:
Macrophages from the synovium of active rheumatoid arthritis
exhibit an activin A-dependent pro-inflammatory profile. J Pathol.
235:515–526. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Samaniego R, Palacios BS, Domiguez-Soto Á,
Vidal C, Salas A, Matsuyama T, Sánchez-Torres C, de la Torre I,
Miranda-Carús ME, Sánchez-Mateos P and Puig-Kröger A: Macrophage
uptake and accumulation of folates are polarization-dependent in
vitro and in vivo and are regulated by activin A. J Leukoc Biol.
95:797–808. 2014. View Article : Google Scholar : PubMed/NCBI
|
20
|
Nüsing RM and Barsig J: Induction of
prostanoid, nitric oxide, and cytokine formation in rat bone marrow
derived macrophages by activin A. Br J Pharmacol. 127:919–926.
1999. View Article : Google Scholar : PubMed/NCBI
|
21
|
Yamashita S, Maeshima A, Kojima I and
Nojima Y: Activin A is a potent activator of renal interstitial
fibroblasts. J Am Soc Nephrol. 15:91–101. 2004. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ohga E, Matsuse T, Teramoto S, Katayama H,
Nagase T, Fukuchi Y and Ouchi Y: Effects of activin A on
proliferation and differentiation of human lung fibroblasts.
Biochem Biophys Res Commun. 228:391–396. 1996. View Article : Google Scholar : PubMed/NCBI
|
23
|
Wang Y, Wang S, Wier WG, Zhang Q, Jiang H,
Li Q, Chen S, Tian Z, Li Y, Yu X, et al: Exercise improves the
dilatation function of mesenteric arteries in postmyocardial
infarction rats via a PI3K/Akt/eNOS pathway-mediated mechanism. Am
J Physiol Heart Circ Physiol. 299:H2097–H2106. 2010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Maeshima A, Mishima K, Yamashita S,
Nakasatomi M, Miya M, Sakurai N, Sakairi T, Ikeuchi H, Hiromura K,
Hasegawa Y, et al: Follistatin, an activin antagonist, ameliorates
renal interstitial fibrosis in a rat model of unilateral ureteral
obstruction. Biomed Res Int. 2014:3761912014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Mabe AM, Hoard JL, Duffourc MM and Hoover
DB: Localization of cholinergic innervation and neurturin receptors
in adult mouse heart and expression of the neurturin gene. Cell
Tissue Res. 326:57–67. 2006. View Article : Google Scholar : PubMed/NCBI
|
26
|
Frangogiannis NG: Regulation of the
inflammatory response in cardiac repair. Circ Res. 110:159–173.
2012. View Article : Google Scholar : PubMed/NCBI
|
27
|
Harrison CA, Gray PC, Vale WW and
Robertson DM: Antagonists of activin signaling: Mechanisms and
potential biological applications. Trends Endocrinol Metab.
16:73–78. 2005. View Article : Google Scholar : PubMed/NCBI
|
28
|
Jones KL, Mansell A, Patella S, Scott BJ,
Hedger MP, de Kretser DM and Phillips DJ: Activin A is a critical
component of the inflammatory response, and its binding protein,
follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci
USA. 104:pp. 16239–16244. 2007; View Article : Google Scholar : PubMed/NCBI
|
29
|
Kumar R, Yong QC and Thomas CM: Do
multiple nuclear factor kappa B activation mechanisms explain its
varied effects in the heart? Ochsner J. 13:157–165. 2013.PubMed/NCBI
|
30
|
Brown MA and Jones WK: NF-kappaB action in
sepsis: The innate immune system and the heart. Front Biosci.
9:1201–1217. 2004. View
Article : Google Scholar : PubMed/NCBI
|
31
|
Fukushima N, Matsuura K, Akazawa H, Honda
A, Nagai T, Takahashi T, Seki A, Murasaki KM, Shimizu T, Okano T,
et al: A crucial role of activin A-mediated growth hormone
suppression in mouse and human heart failure. PLoS One.
6:e279012011. View Article : Google Scholar : PubMed/NCBI
|
32
|
Carter BD, Kaltschmidt C, Kaltschmidt B,
Offenhäuser N, Böhm-Matthaei R, Baeuerle PA and Barde YA: Selective
activation of NF-kappa B by nerve growth factor through the
neurotrophin receptor p75. Science. 272:542–545. 1996. View Article : Google Scholar : PubMed/NCBI
|
33
|
Lindholm D, Heumann R, Meyer M and Thoenen
H: Interleukin-1 regulates synthesis of nerve growth factor in
non-neuronal cells of rat sciatic nerve. Nature. 330:658–659. 1987.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Phillips DJ, Jones KL, Scheerlinck JY,
Hedger MP and de Kretser DM: Evidence for activin A and follistatin
involvement in the systemic inflammatory response. Mol Cell
Endocrinol. 180:155–162. 2001. View Article : Google Scholar : PubMed/NCBI
|
35
|
Zhou S, Chen LS, Miyauchi Y, Miyauchi M,
Kar S, Kangavari S, Fishbein MC, Sharifi B and Chen PS: Mechanisms
of cardiac nerve sprouting after myocardial infarction in dogs.
Circ Res. 95:76–83. 2004. View Article : Google Scholar : PubMed/NCBI
|
36
|
Wu X, Jiang H, Yu L, Hu X and Liu W:
Desipramine pretreatment improves sympathetic remodeling and
ventricular fibrillation threshold after myocardial ischemia. J
Biomed Biotechnol. 2012:7329092012. View Article : Google Scholar : PubMed/NCBI
|
37
|
Suzuki K, Kobayashi T, Funatsu O, Morita A
and Ikekita M: Activin A induces neuronal differentiation and
survival via ALK4 in a SMAD-independent manner in a subpopulation
of human neuroblastomas. Biochem Biophys Res Commun. 394:639–645.
2010. View Article : Google Scholar : PubMed/NCBI
|
38
|
Bao YL, Tsuchida K, Liu B, Kurisaki A,
Matsuzaki T and Sugino H: Synergistic activity of activin A and
basic fibroblast growth factor on tyrosine hydroxylase expression
through Smad3 and ERK1/ERK2 MAPK signaling pathways. J Endocrinol.
184:493–504. 2005. View Article : Google Scholar : PubMed/NCBI
|